Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The endoplasmic reticulum (ER) is a continuous membrane system that forms a series of flattened sacs within the cytoplasm of eukaryotic cells, serving as a primary site for protein synthesis, folding, and quality control (StatPearls, 2023). It is also essential for lipid biosynthesis, carbohydrate metabolism, and the regulation of intracellular calcium storage (Nature Reviews Molecular Cell Biology, 2018). The ER is categorized into the rough ER, which is associated with ribosomes, and the smooth ER, which lacks ribosomes and is involved in detoxification and lipid production (Wikipedia, 2024). Dysregulation of ER homeostasis leads to ER stress and the activation of the Unfolded Protein Response (UPR), a signaling pathway that can either promote cell survival or trigger apoptosis (Frontiers in Molecular Biosciences, 2021). Chronic ER stress is a hallmark of several diseases, including neurodegenerative conditions like Alzheimer's disease, metabolic disorders such as type 2 diabetes, and various cancers (Journal of Cell Biology, 2017). Although the ER is a cellular compartment rather than a single molecular target, it contains numerous specific proteins, such as the SERCA pump and GRP78, that are targeted by pharmacological agents (Pharmacological Reviews, 2011). Drugs like thapsigargin and tunicamycin are used in research to induce ER stress, while chemical chaperones like 4-phenylbutyrate are explored for their ability to alleviate protein misfolding (PubMed, 2019). Therapeutic intervention at the ER level remains challenging due to the risk of disrupting essential cellular processes across multiple organ systems (Cell Death & Disease, 2020).
Modulation of the Unfolded Protein Response (UPR), inhibition of ER-resident calcium pumps (e.g., SERCA), and chemical chaperoning to assist in protein folding.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Endoplasmic reticulum (ER) (ER).